imf digital currencies, snippets

Huang Hongfei, former CFO of McDonald's China, joined the company? Bawang Chaji: No response. Recently, it was reported in the market that Huang Hongfei, the former CFO of McDonald's China, recently left his post and joined Bawang Chaji after a short break. In response to this news, Bawang Chaji said that he would not respond. According to public information, Huang Hongfei joined McDonald's around 1995 and played an important role in the financial and strategic planning of McDonald's China. He was one of the key figures who witnessed the development of McDonald's China. (SSE)Four departments: By 2027, the digital transformation of specialized and innovative small and medium-sized enterprises should be completely reformed. The Ministry of Industry and Information Technology, the Ministry of Finance, the People's Bank of China and the General Administration of Financial Supervision issued the Special Action Plan for Digital Empowerment of Small and Medium-sized Enterprises (2025-2027). According to the notice, by 2027, the "100-city" pilot project for the digital transformation of small and medium-sized enterprises has achieved solid results, and the digital transformation of specialized and special small and medium-sized enterprises should be completely reformed, forming a number of transformation benchmarks with a digital level of three or four; The digital level of the pilot provincial-level specialized and innovative small and medium-sized enterprises has reached the second level and above, and the numerical control rate of key processes of industrial small and medium-sized enterprises in the country has reached 75%; The cloud access rate of small and medium-sized enterprises exceeds 40%. Initially build a digital transformation ecology of small and medium-sized enterprises, which is coordinated by the Ministry and the province, the integration of large and medium-sized enterprises, the adaptation of supply and demand in key scenes, and the strong public service guarantee, and empower small and medium-sized enterprises to specialize in special new development.Market News: It is reported that Morgan Stanley will buy a mortgage loan from Santander Bank, worth about 900 million euros.

Yiling Pharmaceutical Co., Ltd.: The application for clinical trial of Lianhua Yuping Granule was approved, and Yiling Pharmaceutical announced that Beijing Yiling, a wholly-owned subsidiary, received the Notice of Approval for Clinical Trial of Drugs approved and issued by National Medical Products Administration on December 12, 2024, and agreed to carry out clinical trial of Lianhua Yuping Granule for qi deficiency syndrome of common cold.Russian Defense Ministry: Russian air defense forces shot down 13 Ukrainian drones in Kursk, Belgorod, Rostov and Lipetsk last night.Bank of Communications: Wang Wenjin resigned as business director. Due to job transfer, Wang Wenjin has submitted a written report to the board of directors of the company and resigned as business director (corporate and institutional business). His resignation will take effect on December 13, 2024.

A number of officials from Turkey and Qatar will visit Syria to meet with the Syrian transitional government. On the 12th local time, the Syrian Ministry of Information announced that the Turkish Foreign Minister, the head of the intelligence department and the head of Qatar's national security department will visit Syria and meet with the leader of the Sharm el-Liberation Organization, Giulani, and the caretaker Prime Minister of the Syrian transitional government, Bashir. Up to now, Turkish and Qatar officials have not announced relevant news.Bank of Communications: Wang Wenjin resigned as business director. Due to job transfer, Wang Wenjin has submitted a written report to the board of directors of the company and resigned as business director (corporate and institutional business). His resignation will take effect on December 13, 2024.Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.